The mitochondria target drug avocatin B synergizes with induction chemotherapeutics to induce leukemia cell death

Acute myeloid leukemia (AML) is a devastating hematological malignancy characterized by the accumulation of myeloid progenitors that fail to terminally differentiate.[1] Standard induction therapy ...